Latest news & press

nanoTherics Wins “Impact Through Innovation” Lord Stafford Award

nanoTherics, a scientific medical research devices company founded in 2007 following on from cutting-edge biomedical research conducted at Keele University and the University of Florida, is pleased to announce it has won the “Impact Through Innovation” Lord Stafford Award for the commercial exploitation of a novel gene transfection technology.

nanoTherics’s primary business is supply of scientific devices and associated products to research laboratories in the pharmaceutical and biotechnology industries as well as academia. The Company’s products apply a patented technology using nanoparticles and magnetic fields to facilitate improved delivery of biomolecules, such as DNA, into living cells. The medium to long-term opportunity for this approach relates to more effective non-viral gene therapy, an area demanding safer technology to treat genetic diseases such as cystic fibrosis.

Dr Neil Farrow, Chief Operating Officer and Founder Director, said, “We are delighted to have won this Award. For an innovative, technology and product driven company, public acknowledgement like this provides external validation of the value of the systems we are developing.” He added, “This award is given to businesses demonstrating greatest potential for products or services developed in association with a West Midlands University. The research conducted at Keele University into improved non-viral transfection technologies, which have resulted in the efficient, effective transfection-based products now forming the foundation of nanoTherics, provides an excellent example of how these collaborations can result in valuable products with market demand. Using this technology nanoTherics will be introducing a range of systems which will shortly be initiated with the launch of the magneFect nano, a flexible device which provides up to 1000-fold better than cationic lipid agents for short transfection times.”